Looking forward to understanding and reducing colorectal cancer risk in inflammatory bowel disease

Affiliations

¹ Division of Gastroenterology and Hepatology, University of California, San Francisco, San Francisco, California. Electronic address: Fernando.Velayos@ucsf.edu.
² The Dr Henry D. Janowitz Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York.

Editorial

Fernando S Velayos et al. Gastroenterology. 2013 Jul.

. 2013 Jul;145(1):47-49.

doi: 10.1053/j.gastro.2013.05.023. Epub 2013 May 29.

¹ Division of Gastroenterology and Hepatology, University of California, San Francisco, San Francisco, California. Electronic address: Fernando.Velayos@ucsf.edu.
² The Dr Henry D. Janowitz Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York.

No abstract available

Comment on

Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
Beaugerie L, Svrcek M, Seksik P, Bouvier AM, Simon T, Allez M, Brixi H, Gornet JM, Altwegg R, Beau P, Duclos B, Bourreille A, Faivre J, Peyrin-Biroulet L, Fléjou JF, Carrat F; CESAME Study Group. Beaugerie L, et al. Gastroenterology. 2013 Jul;145(1):166-175.e8. doi: 10.1053/j.gastro.2013.03.044. Epub 2013 Mar 27. Gastroenterology. 2013. PMID: 23541909